Mark Johanson has served as President, Chief Executive Officer and Chairman of Audax Medical, Inc., a developer of orthopedic regenerative biomaterials, since founding the company in April, 2009. Mark manages all aspects of Audax’s operations including finance, capital funding, business development, research & development, intellectual property and regulatory affairs. Since founding Audax he has raised over $6.5 million in early-stage funding, supporting the company through its current pre-clinical development stage. Mark is an accomplished entrepreneur with over 25 years of experience in the medical device, biomaterials and regenerative biotechnology spaces. He is also an inventor holding 26 issued patents in the areas of orthopedics, cardiology, biomaterials and surgical methods.
Mark founded Scandius BioMedical, Inc. in 2000, a developer of minimally invasive orthopedic sports medicine surgical products for knee arthroscopy. Mark served as President, Chief Executive Officer and Chairman of Scandius until the company’s acquisition by Covidien in 2007. He lead the formation of one of the industry’s premier Clinical Advisory Boards consisting of over ten professional sports head team physicians. During the company’s growth stages he raised more than $20 million in capital funding from early-stage individual investors and leading venture capital firms. He is also a Founder and Director of Parios Regenerative Sciences, Inc., Dental Regen, Inc. and Fortia Medical, Inc. Mark’s prior experience includes engineering and management positions at Innovasive Devices, Inc., acquired by Johnson & Johnson in 2000, and Medtronic Interventional Vascular.
Mark holds a BS from the University of Lowell School of Engineering. He serves on the University of Massachusetts-Lowell Manning School of Management Advisory Board and is an Advisor to the Isenberg School of Management at the University of Massachusetts-Amherst.